Advanced Techniques in Diagnostic Microbiology

27. Molecular Differential Diagnoses 503
panel. We thank Drs. Robert Cooksey and Glenn P. Morlock from the CDC TB
Laboratory Research and Dr. Catherine McKinstry from the Los Angeles County
Department of Health for help with the MDD System for TB Drug Resistance
Mutations development. We thank Drs. Lee Cancio, Edward Horvath, and Charles
Guymon from USAISR-Fort Sam Houston for their help with the design and validation
of the MDD Systems for HAI I and II. And we thank Drs. YiWei Tang
and Charles W. Stratton from Vanderbilt University for collaborating in the development
and validation of the MDD System for GPCC. The author also wishes to
thank the following colleagues at Genaco for their contribution in developing the
Templex technology and products and help with critical reading of the manuscript:
Shanjuan H. Lum, Christina L. Teng-Renzelman, Kassi J. Cronin, Michele B. Weber,
Rebecca S. Miller, Karen D. Tracy, Robert K. Vereen, Amy G. Fruchtnicht,
Lisa E. Varnavas, Kelly Millstead, Qunying Yang, Chiung Mei Lu, and Dennis L.
Grimaud.
References
Adams, C. & Brantner, V. V. (2004). Estimating the costs of new drug development: is it really
$802 m? Social Science Research Network. http://papers.ssrn.com/sol3/papers.cfm?
abstract id=640563
Dean, A., Lamson, D. M., Han, J., et al. (2005). Evaluation of Genaco’s Molecular Differential
Diagnostic technology for the detection of RNA respiratory viruses. Abstract
#67663. 22nd Annual Clinical Virology Symposium and Annual Meeting of the Pan
American Society for Clinical Virology.
Dunbar, S. A., Vander Zee, C. A., Oliver, K. G., Karem, K. L., & Jacobson, J. W. (2003).
Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications
of the Luminex LabMAP system. J Microbiol Methods, 53, 245–252.
Farr, B. M. & Bellingan, G. (2004). Pro/con clinical debate: isolation precautions for all
intensive care unit patients with methicillin-resistant Staphylococcus aureus colonization
are essential. Crit Care, 8(3), 153–156.
Farr, B. M., Salgado, C. D., Karchmer, T. B., & Sherertz, R. (2001). Can antibiotic-resistant
nosocomial infections be controlled? Lancet Infect Dis, 1, 38–45.
Fields, B. S., et al. (2005) Collaborative development of a multiplex assay system for
respiratory infections. Personal communications.
Francois, P., Renzi, G., Pittet, D., et al. (2004). A novel multiplex real-time PCR assay
for rapid typing of major staphylococcal cassette chromosome mec elements. J Clin
Microbiol, 42(7), 3309–3312
Gröndahl, B., Puppe, W., Hoppe, A., Kühne, I., Josef A. I., Weigl, J. A. I., & Schmitt,
H-J. (1999). Rapid identification of nine microorganisms causing acute respiratory tract
infections by single-tube multiplex reverse transcription-PCR: feasibility study. J Clin
Microbiol, 37(1), 1–7.
Hallin, M., Maes, N., Byl, B., Jacobes, F., De Gheldre, Y., & Struelens, M. J. (2003). Clinical
impact of a PCR assay for identification of Staphylococcus aureus and determination of
methicillin resistance directly from blood cultures. J Clin Microbiol, 41(8) 3942–3944.
Heffler, S., Smith, S., and Keehan, S., et al. (2004). Health spending projections through
2013. Health Affairs Web Exclusive, W4-79 through W4-93. http://content.healthaffairs.
org/cgi/content/full/hlthaff.w4.79v1/DC1